Quantcast
Channel: NoCamels News Flash » NSTI
Viewing all articles
Browse latest Browse all 2

Atox Bio Raising Millions Following Successful Clinical Trial

0
0

Atox Bio Raising Millions Following Successful Clinical TrialIsraeli company Atox Bio Ltd. has reported a successful clinical trial of its AB103 treatment for Necrotizing Soft-Tissue Infection (NSTI). Financial magazine Globes reports that due to the successful trial, that has shown that the drug was both effective and safe, the company has begun raising millions of dollars. NSTI is a life-threatening bacterial infection with significant morbidity and high mortality rate.


Viewing all articles
Browse latest Browse all 2

Latest Images

Trending Articles





Latest Images